Endocrine responses after d-fenfluramine and ipsapirone challenge : Further support for cloninger's tridimensional model of personality

The tridemensional model of personality introduced by Cloninger relates aspects of novelty seeking to the dopaminergic, harm avoidance (HA) to the serotonergic, and reward dependence to the noradrenergic neurotransmitter system. Using a neuroendocrine challenge paradigm, this study investigates whet...

Full description

Saved in:
Bibliographic Details
Published inNeuropsychobiology Vol. 41; no. 1; pp. 38 - 47
Main Authors HENNIG, J, TOLL, C, SCHONLAU, P, ROHRMANN, S, NETTER, P
Format Conference Proceeding Journal Article
LanguageEnglish
Published Basel Karger 2000
S. Karger AG
Subjects
Online AccessGet full text
ISSN0302-282X
1423-0224
DOI10.1159/000026631

Cover

Abstract The tridemensional model of personality introduced by Cloninger relates aspects of novelty seeking to the dopaminergic, harm avoidance (HA) to the serotonergic, and reward dependence to the noradrenergic neurotransmitter system. Using a neuroendocrine challenge paradigm, this study investigates whether subjects characterized by blunted cortisol (CORT) responses after ipsapirone (IPS) relate to different subfactors of HA from those characterized by blunted prolactin (PRL) responses after treatment with d-fenfluramine (D-FEN). Moreover, subjects blunted in both responses should differ in scale values of subfactors of HA from those with only one or no blunted reactions. In the first part of the experiment, 16 healthy male volunteers were treated with 15 mg D-FEN. The second part of the study (about 1 year later) consists of a challenge with the partial 5-hydroxytryptamine-1a (5-HT(1a)) agonist IPS (10 mg) in the same subjects. The results indicate that blunted PRL responses are accompanied by high values in HA, while the main effect of IPS responsivity did not relate significantly to this dimension. With respect to the subscales of HA, subjects blunted in both responses (PRL-/C-) exhibit significantly higher levels in fatigability and asthenia when compared to all other groups (PRL-/C+, PRL+/C-,PRL+/C+). The data demonstrate that combined challenge tests may shed more light on the biological basis of personality and that HA and most clearly fatigability and asthenia relate to the 5-HT system.
AbstractList The tridemensional model of personality introduced by Cloninger relates aspects of novelty seeking to the dopaminergic, harm avoidance (HA) to the serotonergic, and reward dependence to the noradrenergic neurotransmitter system. Using a neuroendocrine challenge paradigm, this study investigates whether subjects characterized by blunted cortisol (CORT) responses after ipsapirone (IPS) relate to different subfactors of HA from those characterized by blunted prolactin (PRL) responses after treatment with d-fenfluramine (D-FEN). Moreover, subjects blunted in both responses should differ in scale values of subfactors of HA from those with only one or no blunted reactions. In the first part of the experiment, 16 healthy male volunteers were treated with 15 mg D-FEN. The second part of the study (about 1 year later) consists of a challenge with the partial 5-hydroxytryptamine-1a (5-HT(1a)) agonist IPS (10 mg) in the same subjects. The results indicate that blunted PRL responses are accompanied by high values in HA, while the main effect of IPS responsivity did not relate significantly to this dimension. With respect to the subscales of HA, subjects blunted in both responses (PRL-/C-) exhibit significantly higher levels in fatigability and asthenia when compared to all other groups (PRL-/C+, PRL+/C-,PRL+/C+). The data demonstrate that combined challenge tests may shed more light on the biological basis of personality and that HA and most clearly fatigability and asthenia relate to the 5-HT system.
The tridemensional model of personality introduced by Cloninger relates aspects of novelty seeking to the dopaminergic, harm avoidance (HA) to the serotonergic, and reward dependence to the noradrenergic neurotransmitter system. Using a neuroendocrine challenge paradigm, this study investigates whether subjects characterized by blunted cortisol (CORT) responses after ipsapirone (IPS) relate to different subfactors of HA from those characterized by blunted prolactin (PRL) responses after treatment with d-fenfluramine (D-FEN). Moreover, subjects blunted in both responses should differ in scale values of subfactors of HA from those with only one or no blunted reactions. In the first part of the experiment, 16 healthy male volunteers were treated with 15 mg D-FEN. The second part of the study (about 1 year later) consists of a challenge with the partial 5-hydroxytryptamine-1a (5-HT(1a)) agonist IPS (10 mg) in the same subjects. The results indicate that blunted PRL responses are accompanied by high values in HA, while the main effect of IPS responsivity did not relate significantly to this dimension. With respect to the subscales of HA, subjects blunted in both responses (PRL-/C-) exhibit significantly higher levels in fatigability and asthenia when compared to all other groups (PRL-/C+, PRL+/C-,PRL+/C+). The data demonstrate that combined challenge tests may shed more light on the biological basis of personality and that HA and most clearly fatigability and asthenia relate to the 5-HT system.The tridemensional model of personality introduced by Cloninger relates aspects of novelty seeking to the dopaminergic, harm avoidance (HA) to the serotonergic, and reward dependence to the noradrenergic neurotransmitter system. Using a neuroendocrine challenge paradigm, this study investigates whether subjects characterized by blunted cortisol (CORT) responses after ipsapirone (IPS) relate to different subfactors of HA from those characterized by blunted prolactin (PRL) responses after treatment with d-fenfluramine (D-FEN). Moreover, subjects blunted in both responses should differ in scale values of subfactors of HA from those with only one or no blunted reactions. In the first part of the experiment, 16 healthy male volunteers were treated with 15 mg D-FEN. The second part of the study (about 1 year later) consists of a challenge with the partial 5-hydroxytryptamine-1a (5-HT(1a)) agonist IPS (10 mg) in the same subjects. The results indicate that blunted PRL responses are accompanied by high values in HA, while the main effect of IPS responsivity did not relate significantly to this dimension. With respect to the subscales of HA, subjects blunted in both responses (PRL-/C-) exhibit significantly higher levels in fatigability and asthenia when compared to all other groups (PRL-/C+, PRL+/C-,PRL+/C+). The data demonstrate that combined challenge tests may shed more light on the biological basis of personality and that HA and most clearly fatigability and asthenia relate to the 5-HT system.
Author ROHRMANN, S
TOLL, C
HENNIG, J
NETTER, P
SCHONLAU, P
Author_xml – sequence: 1
  givenname: J
  surname: HENNIG
  fullname: HENNIG, J
  organization: Department of Psychology, University of Giessen, Germany
– sequence: 2
  givenname: C
  surname: TOLL
  fullname: TOLL, C
  organization: Department of Psychology, University of Giessen, Germany
– sequence: 3
  givenname: P
  surname: SCHONLAU
  fullname: SCHONLAU, P
  organization: Department of Psychology, University of Giessen, Germany
– sequence: 4
  givenname: S
  surname: ROHRMANN
  fullname: ROHRMANN, S
  organization: Department of Psychology, University of Giessen, Germany
– sequence: 5
  givenname: P
  surname: NETTER
  fullname: NETTER, P
  organization: Department of Psychology, University of Giessen, Germany
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1491064$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/10629434$$D View this record in MEDLINE/PubMed
BookMark eNpdkE1LHTEUhoNY9Hrron-ghFJ0NW0-5k4Sd0XUFoRuWnA3ZDInGskk05yZhb-gf9uIVwo9mxfO-5wP3hNymHICQj5w9oXznfnKaomuk_yAbHgrZMOEaA_JhkkmGqHF3TE5QXxkjLdGmSNyzFknTCvbDfl7lcbsSkhAC-CcEwJS6xcodGw8JB_XYqcX26aRhhntHEq9Tt2DjRHSPdALer2W5aFO4DrPuSzU50JdzClUu5wjXUoYwwQJQ0420imPEGn2dIaCL52wPL0n77yNCKd73ZLf11e_Lr83tz9vflx-u23uJVdLI1XHPWNaGy06NwgzenDOi51X0jg-DMopP2it_E503gweFNfMSiV348CVk1ty9rp3LvnPCrj0U0AHMdoEecVeMd0ZVjPckk__gY95LfVZ7IWUFdBVtuTjHlqHCcZ-LmGy5al_y7cCn_eARWejLza5gP-41lS0lc_JSoxl
CODEN NPBYAL
ContentType Conference Proceeding
Journal Article
Copyright 2000 INIST-CNRS
Copyright 2000 S. Karger AG, Basel
Copyright S. Karger AG Jan 2000
Copyright_xml – notice: 2000 INIST-CNRS
– notice: Copyright 2000 S. Karger AG, Basel
– notice: Copyright S. Karger AG Jan 2000
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7U7
7X7
7XB
88A
88E
88G
88I
8AF
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2M
M2P
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
S0X
7X8
DOI 10.1159/000026631
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Toxicology Abstracts
ProQuest - Health & Medical Complete保健、医学与药学数据库
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
Science Database (Alumni Edition)
STEM Database
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Database
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Psychology Database
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
SIRS Editorial
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
SIRS Editorial
ProQuest Health & Medical Complete (Alumni)
ProQuest AP Science
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
Toxicology Abstracts
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest One Psychology
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: AUTh Library subscriptions: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Pharmacy, Therapeutics, & Pharmacology
EISSN 1423-0224
EndPage 47
ExternalDocumentID 48628730
10629434
1491064
Genre Clinical Trial
Randomized Controlled Trial
Journal Article
GroupedDBID ---
.GJ
0R~
0~5
0~B
123
29N
30W
325
36B
3O.
3V.
4.4
53G
5RE
7X7
88A
88E
88I
8AF
8AO
8FE
8FH
8FI
8FJ
8UI
AAKET
AAYIC
ABIVO
ABPAZ
ABPTK
ABUWG
ABZSI
ACGFS
ACGOD
ACHQM
ACNCT
ACPRK
ACPSR
ADAGL
ADBBV
ADGES
AENEX
AEYAO
AFFNX
AFKRA
AFRAH
AHMBA
ALDHI
ALMA_UNASSIGNED_HOLDINGS
AZPMC
AZQEC
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
DWQXO
E0A
EBS
EJD
EMB
EMOBN
F5P
FB.
FYUFA
GNUQQ
HCIFZ
HZ~
IQODW
IY7
KUZGX
LK8
M0L
M1P
M2M
M2P
M7P
N9A
O1H
O9-
OVD
PQQKQ
PROAC
PSQYO
PSYQQ
RIG
RKO
RXVBD
S0X
SV3
TEORI
UJ6
UKHRP
ZGI
ZXP
ABBTS
ABJNI
ABWCG
ACQXL
AFJJK
AFSIO
AHFRZ
ALIPV
CGR
CUY
CVF
CYUIP
ECM
EIF
HMCUK
NPM
7TK
7U7
7XB
8FK
C1K
K9.
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
PUEGO
Q9U
7X8
ID FETCH-LOGICAL-g317t-3761f00889826cb29dfeccf25f739c1bb7c7fb887f526f9bfe7180a3735db17c3
IEDL.DBID 7X7
ISSN 0302-282X
IngestDate Thu Sep 04 23:26:52 EDT 2025
Sat Aug 23 14:40:28 EDT 2025
Wed Feb 19 01:20:57 EST 2025
Sun Oct 22 16:07:50 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Human
Ipsapirone
Adenohypophyseal hormone
Prolactin
Adrenal hormone
Fenfluramine
Personality
Serotonine receptor
Serotonin agonist
Hydrocortisone
Glucocorticoid
Language English
License CC BY 4.0
Copyright 2000 S. Karger AG, Basel
LinkModel DirectLink
MeetingName Traits as Dispositions for Psychopathology
MergedId FETCHMERGED-LOGICAL-g317t-3761f00889826cb29dfeccf25f739c1bb7c7fb887f526f9bfe7180a3735db17c3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
content type line 23
ObjectType-Undefined-3
PMID 10629434
PQID 233423823
PQPubID 32889
PageCount 10
ParticipantIDs proquest_miscellaneous_70869042
proquest_journals_233423823
pubmed_primary_10629434
pascalfrancis_primary_1491064
PublicationCentury 2000
PublicationDate 2000
2000-00-00
20000101
PublicationDateYYYYMMDD 2000-01-01
PublicationDate_xml – year: 2000
  text: 2000
PublicationDecade 2000
PublicationPlace Basel
PublicationPlace_xml – name: Basel
– name: Switzerland
PublicationTitle Neuropsychobiology
PublicationTitleAlternate Neuropsychobiology
PublicationYear 2000
Publisher Karger
S. Karger AG
Publisher_xml – name: Karger
– name: S. Karger AG
SSID ssj0014979
Score 1.6719756
Snippet The tridemensional model of personality introduced by Cloninger relates aspects of novelty seeking to the dopaminergic, harm avoidance (HA) to the...
SourceID proquest
pubmed
pascalfrancis
SourceType Aggregation Database
Index Database
StartPage 38
SubjectTerms Adult
Behavioral psychophysiology
Biological and medical sciences
Cross-Over Studies
Double-Blind Method
Fenfluramine - administration & dosage
Fenfluramine - pharmacology
Fundamental and applied biological sciences. Psychology
Hormones and behavior
Humans
Hydrocortisone - blood
Male
Models, Neurological
Neurotransmitter Agents - physiology
Personality - physiology
Personality Inventory
Prolactin - blood
Prospective Studies
Psychology. Psychoanalysis. Psychiatry
Psychology. Psychophysiology
Pyrimidines - administration & dosage
Pyrimidines - pharmacology
Reference Values
Serotonin Agents - administration & dosage
Serotonin Agents - pharmacology
Title Endocrine responses after d-fenfluramine and ipsapirone challenge : Further support for cloninger's tridimensional model of personality
URI https://www.ncbi.nlm.nih.gov/pubmed/10629434
https://www.proquest.com/docview/233423823
https://www.proquest.com/docview/70869042
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NT9wwEB21cKlUVRTasnx1DhVciJo4XxsuFUW7Qj0ghEDa28qO7QoJsmm8e9g_wO9mxs7uqof27MhKMvbMG3vmPYBvuiqroWTVAAIHUWbyLBrm0kbKWq0JYSSp9myfN8X1Q_Zrkk_62hzXl1WufKJ31HpW8xn5d5EyV91QpD_aPxGLRvHlaq-g8Ra2E0IqvKjLyTrfIuwfqPZS34EsJj2xEAVwz9lIoYml5d630tHvsEHH4t9A0wec8Q586JEiXgbTfoQ3ptmFvcuGsuTnJZ6ir930h-K7cHobGKiX53i_aahy5_6xNTf1cg9eRg19Knf8YReqY41DrxOOOrKGFUs6-czDstH42DrZch-cwXolunKB40XHqBHdomXwjgR78erJH-ua7szhvHvUrBkQ-D7Qa-3gzGK7wf2f4GE8ur-6jnophug3AYw5u6HExlwSRelIrUSlLdneityWaVUnSpV1aRU5LJuLwlbKGop5sUzLNNcqKev0M2w19Lb7gDG3suqMsajOciuULAyBCEtYoRpmIh7A8V8WmbaBdoOSFII2RTaAw5WFpv1-c9P16hjA1_UobRS-_ZCNmS3ctIxZfCsTA_gSzLqZOC4E0-Qd_HfmQ3gX2vD5-OUItubdwhwTIJmrE7_sTmD75-jm9u4VS4jkUQ
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2VcgAJIWj5WErpHKBcGjVrO8kGCaGqdLWlpeKwlfYWkthGldpsmuwK7R_g3_AfmbE3u-IAt54dWYlnxn7jzLwH8FanSTrIWTWAwEGgTKSCQZTboLBWa0IYfakd2-dFPLpUXybRZAN-d70wXFbZ7Yluo9bTku_ID4VkrrqBkJ_q24BFo_jnaqeg4b3izCx-UsbWfjz9TOZ9J8TwZHw8CpaiAsEPOipnHFB9G3JxDwHrshCptvQVVkQ2kWnZL4qkTGxBoWcjEdu0sIZ27zCXiYx00U9KSfPeg_tKhoqp-pPJKr-jXMNT-0nX8SwmSyIjAgyOI5KOQpaye1TnLS2_9boZ_wa27oAbPoHHS2SKR96VnsKGqbZg-6iirPxmgfvoakXdJfwW7H_zjNeLAxyvG7jaA_fYigt7sQ2_TipaWu4wxMZX45oWnS456sAaVkhp8hseziuNV3Wb19x3Z7DsRF4-4HDeMErFdl5zsoAEs_H42l0jm-Z9i7PmSrNGgecXQaftg1OL9TrPeAaXd2Kl57BZ0du-BAy5dVYrxr5aRVYUeWwItFjCJulAibAHu39ZJKs9zQclRQSlYtWDnc5C2TK-22zljT3YW41SYPLflrwy03mbJSGLfSnRgxferOuJw1gwLd-r_868Bw9G46_n2fnpxdkOPPQUAHz18xo2Z83c7BIYmhVvnAsifL9rn_8Drr4gEA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2VIiGkCkHLx1JK5wDl0qhZOx8bJISqtquWoqqHVtpbiGMbVaLZNNkV2j_Af-LfMWMnu-IAt54dWUlmxn5jz7wH8E5naTYqWDWAwEEQmTgKRnFhA2Wt1oQwhlI7ts-L5PQ6-jKJJ2vwu--F4bLKfk10C7WelnxGfiAkc9WNhDywXVXE5fH4c30XsIAUX7T2ahreQ87N4idlb-2ns2My9XshxidXR6dBJzAQfKdtc8bBNbQhF_oQyC6VyLSlL7IitqnMyqFSaZlaRWFoY5HYTFlDK3lYyFTGWg3TUtK8D-BhKiPJ1WTpZJnrUd7haf6k634Wk47UiMCD44ukbZFl7TbqoiVTWK-h8W-Q6za78VN40qFUPPRu9QzWTLUJW4cVZei3C9xDVzfqDuQ3Ye_Ss18v9vFq1czV7rvHlrzYiy34dVLRb-ZuQ2x8Za5p0WmUow6sYbWUprjl4aLSeFO3Rc09eAbLXvDlI47nDSNWbOc1Jw5IkBuPfrgjZdN8aHHW3GjWK_BcI-h0fnBqsV7lHM_h-l6s9ALWK3rbV4Aht9HqiHGwjmIrVJEYAjCWcEo2ikQ4gJ2_LJLXnvKDEiSCVUk0gO3eQnkX622-9MwB7C5HKUj55qWozHTe5mnIwl-RGMBLb9bVxGEimKLv9X9n3oVH5O3517OL82147NkA-BToDazPmrnZIVw0U2-dByJ8u2-X_wPHLCRL
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=proceeding&rft.title=Neuropsychobiology&rft.atitle=Endocrine+responses+after+d-fenfluramine+and+ipsapirone+challenge+%3A+Further+support+for+cloninger%27s+tridimensional+model+of+personality&rft.au=HENNIG%2C+J&rft.au=TOLL%2C+C&rft.au=SCHONLAU%2C+P&rft.au=ROHRMANN%2C+S&rft.date=2000-01-01&rft.pub=Karger&rft.issn=0302-282X&rft.eissn=1423-0224&rft.volume=41&rft.issue=1&rft.spage=38&rft.epage=47&rft_id=info:doi/10.1159%2F000026631&rft.externalDBID=n%2Fa&rft.externalDocID=1491064
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0302-282X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0302-282X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0302-282X&client=summon